Seeking Alpha

The board of ISTA Pharmaceuticals (ISTA +68.1%) confirms that it rejected Valeant...

The board of ISTA Pharmaceuticals (ISTA +68.1%) confirms that it rejected Valeant Pharmaceuticals' (VRX -0.5%) offer of $6.50/share, calling it "grossly inadequate."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|